Nemera has acquired Milfra, a Brazilian manufacturer, enhancing its capabilities and footprint in the Latin American pharmaceutical industry.
Target Information
Nemera has successfully finalized the acquisition of Milfra, a company situated in Jaguariuna, São Paulo, Brazil. Founded in 1966, Milfra is a family-owned business renowned for its expertise in developing and manufacturing medical applicators and oral dosers specifically for the pharmaceutical sector. The company is celebrated for its high-quality production along with the capability to handle high-volume molding and assembly of medical devices, positioning itself as a key player in this industry.
This acquisition enables Milfra to broaden its operational capabilities within Brazil, allowing Nemera to extend its product and service offerings tailored to meet the demands of the pharmaceutical industry in Latin America.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Brazil
Brazil's pharmaceutical industry has witnessed substantial growth in recent years, fueled by an increasing demand for innovative healthcare solutions and a rising population that anticipates improved healthc
Similar Deals
Grupo Fleury → Bioclínico and Pretti
2023
Fundo de Investimento em Saúde administrado pelo BTG Pactual → Eco Medical Center
2023
Viveo → Apijã, Laborsys, Macromed
2021
Nemera
invested in
Milfra
in 2023
in a Buy & Build / Roll-Up deal